Femasys, Inc. (FEMY)
1.75
-0.25
(-12.50%)
USD |
NASDAQ |
Oct 12, 16:00
1.67
-0.08
(-4.57%)
Pre-Market: 08:46
Femasys Enterprise Value : 8.639M for Oct. 12, 2026
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| October 12, 2026 | 8.639M |
| October 09, 2026 | 9.395M |
| October 08, 2026 | 9.531M |
| October 07, 2026 | 9.395M |
| October 06, 2026 | 9.637M |
| October 05, 2026 | 9.455M |
| October 02, 2026 | 9.546M |
| October 01, 2026 | 9.697M |
| September 30, 2026 | 9.878M |
| September 29, 2026 | 9.667M |
| September 28, 2026 | 10.54M |
| September 25, 2026 | 10.85M |
| September 24, 2026 | 10.70M |
| September 23, 2026 | 11.15M |
| September 22, 2026 | 11.09M |
| September 21, 2026 | 11.00M |
| September 18, 2026 | 11.18M |
| September 17, 2026 | 11.06M |
| September 16, 2026 | 11.03M |
| September 15, 2026 | 11.09M |
| September 14, 2026 | 11.42M |
| September 11, 2026 | 11.75M |
| September 10, 2026 | 11.63M |
| September 09, 2026 | 11.90M |
| September 08, 2026 | 11.45M |
| Date | Value |
|---|---|
| September 04, 2026 | 12.36M |
| September 03, 2026 | 12.60M |
| September 02, 2026 | 12.72M |
| September 01, 2026 | 13.20M |
| August 31, 2026 | 13.72M |
| August 28, 2026 | 13.02M |
| August 27, 2026 | 11.78M |
| August 26, 2026 | 12.18M |
| August 25, 2026 | 11.97M |
| August 24, 2026 | 12.36M |
| August 21, 2026 | 12.30M |
| August 20, 2026 | 11.60M |
| August 19, 2026 | 11.54M |
| August 18, 2026 | 10.000M |
| August 17, 2026 | 9.878M |
| August 14, 2026 | 10.27M |
| August 13, 2026 | 10.27M |
| August 12, 2026 | 10.45M |
| August 11, 2026 | 10.45M |
| August 10, 2026 | 10.51M |
| August 07, 2026 | 11.39M |
| August 06, 2026 | 12.27M |
| August 05, 2026 | 12.45M |
| August 04, 2026 | 12.57M |
| August 03, 2026 | 12.33M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Abbott Laboratories | 203.84B |
| AngioDynamics, Inc. | 460.40M |
| Alphatec Holdings, Inc. | 2.227B |
| AtriCure, Inc. | 2.820B |
| Baxter International, Inc. | 19.49B |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -4.469M |
| Revenue (Quarterly) | 0.3318M |
| Total Expenses (Quarterly) | 4.801M |
| EPS Diluted (Quarterly) | -1.331 |
| Gross Profit Margin (Quarterly) | -2.41% |
| Profit Margin (Quarterly) | -1.35K% |
| Earnings Yield | -263.9% |
| Normalized Earnings Yield | -342.79 |